Life sciences

Permeable peptide graphic
Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines
→
JPM branding with Greg Yap and Johnny Hu headshots
Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference​
→
Photo of Mark DePristo, Lucas Nivon, Johnny Hu, and Namrata Anand
Opportunities and Challenges of Applying Generative AI to Designing New Drugs
→
Evan Feinberg, CEO of Genesis Therapeutics
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
→
Video: Early Cancer Detection With Delfi
→
Video: Reengineering Drug Discovery With Recursion
→
Fighting Cancer Through Early Detection and New Therapies: Menlo’s Investments in Delfi and Opna
→
Announcing the Digital Health Founder’s Fellowship
→
Our Investment In Qualio: A New Breed of Quality Management System for Life Sciences
→
Life Science Is Being Transformed by Vertical SaaS
→
The 5 Ps of Therapeutics Investing at Menlo
→
We Are Hiring a Principal with Therapeutics Expertise: Building a Biotech Franchise at Menlo
→
pliant_therapeutics_graphic
Pliant and the 5 Ps of Therapeutics Investing at Menlo
→
Investing in H1: SaaS Healthcare Analytics
→
Rivet_snapshot
Bringing Transparency to Healthcare Transactions: Menlo Ventures Invests in Rivet
→
Benchling founders
Investing in Benchling: Software Accelerating Life Science Innovation
→
Menlo Ventures’ Greg Yap Selected for Aspen Institute’s Health Innovators Fellowship
→
Menlo Announces New $450 Million Fund to Invest in Iconic Entrepreneurs
→
Menlo Welcomes Greg Yap to Focus on Life Sciences Technology
→